EZZ Life Science Holdings (ASX:EZZ) Accounts Payable: A$3.92 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:EZZ EZZ Life Science Holdings Ltd ASX:EZZ
49 GF Score
Price A$0.48
GF Value A$1.45
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is EZZ Life Science Holdings Accounts Payable?

EZZ Life Science Holdings ASX:EZZ +3.23% 49 Accounts Payable is A$3.92 Mil as of Dec. 2025. GuruFocus rates ASX:EZZ with a GF Score™ of 49/100 and a GF Value™ of A$1.45 (Possible Value Trap). The stock has 4 warning signs investors should review.

EZZ Life Science Holdings's Accounts Payable for the quarter that ended in Dec. 2025 was A$3.92 Mil.

EZZ Life Science Holdings's quarterly Accounts Payable declined from Dec. 2024 (A$4.35 Mil) to Jun. 2025 (A$3.46 Mil) but then increased from Jun. 2025 (A$3.46 Mil) to Dec. 2025 (A$3.92 Mil).

EZZ Life Science Holdings's annual Accounts Payable increased from Jun. 2023 (A$2.14 Mil) to Jun. 2024 (A$2.73 Mil) and increased from Jun. 2024 (A$2.73 Mil) to Jun. 2025 (A$3.46 Mil).

EZZ Life Science Holdings Accounts Payable Related Terms

EZZ Life Science Holdings Accounts Payable Historical Data

* Premium members only.

The historical data trend for EZZ Life Science Holdings's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EZZ Life Science Holdings Accounts Payable Chart

EZZ Life Science Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial 1.59 2.39 2.14 2.73 3.46

EZZ Life Science Holdings Semi-Annual Data
Jun20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 4.40 2.73 4.35 3.46 3.92
ASX:EZZ
49GF Score
EZZ Life Science Holdings Ltd ASX:EZZ
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EZZ Life Science Holdings Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of A$3.92 Mil mean?
EZZ Life Science Holdings (ASX:EZZ) has a Accounts Payable of A$3.92 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on EZZ Life Science Holdings and its competitors.
Is EZZ Life Science Holdings' Accounts Payable too high?
EZZ Life Science Holdings' current Accounts Payable is A$3.92 Mil. Overall, EZZ Life Science Holdings has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does EZZ Life Science Holdings' Accounts Payable compare to VRTX and REGN?
EZZ Life Science Holdings' Accounts Payable of A$3.92 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on EZZ Life Science Holdings and its competitors. EZZ Life Science Holdings's current Accounts Payable is A$3.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EZZ Life Science Holdings stock overvalued right now?
Based on GuruFocus' analysis, EZZ Life Science Holdings (ASX:EZZ) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.45, compared to a current price of A$0.48 — trading 66.9% below its estimated fair value. The current Accounts Payable is A$3.92 Mil. EZZ Life Science Holdings' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For EZZ Life Science Holdings (ASX:EZZ), the current Accounts Payable is A$3.92 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EZZ Life Science Holdings (ASX:EZZ) Overvalued in 2026?

Based on GuruFocus' analysis, EZZ Life Science Holdings stock appears to be undervalued. The current stock price of A$0.48 is trading 66.9% below its estimated GF Value™ of A$1.45. GuruFocus considers EZZ Life Science Holdings to be Possible Value Trap.

Key valuation signals for ASX:EZZ:

  • Accounts Payable: A$3.92 Mil
  • GF Value™: A$1.45 vs. price of A$0.48 (66.9% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the ASX:EZZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EZZ Life Science Holdings Business Description

Address 55-59 Parramatta Road, Shop 1, Lidcombe, NSW, AUS, 2141
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.
49GF Score

Get the complete analysis for ASX:EZZ

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.48
Price
A$1.45
GF Value